C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2001
12/20/2001	CA2412615A1 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition
12/20/2001	CA2410228A1 A combination product comprising melagatran and a factor viia inhibitor
12/19/2001	EP1164141A2 Opioid peptides and their use for treatment of pain
12/19/2001	EP1163520A1 Porous coatings bearing ligand arrays
12/19/2001	EP1163263A1 Dalda analogs and their use
12/19/2001	EP1163262A1 Phenylalanine derivatives
12/19/2001	EP1163247A1 Pharmaceutical compositions comprising metal complexes
12/19/2001	EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001	EP1163214A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
12/19/2001	EP0751779B1 Selectively cleavable linkers based on iminodiacetic acid ester bonds
12/19/2001	EP0721449B1 Inhibitors of beta-amyloid protein production
12/19/2001	EP0528820B2 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
12/19/2001	CN1326935A Synthesis of cynnematin
12/19/2001	CA2350857A1 The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
12/18/2001	US6331646 Amorphous N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester
12/18/2001	US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders
12/18/2001	US6331542 Protease inhibitors
12/18/2001	US6331440 Peptide binding the KLVFF-sequence of amyloid-β
12/18/2001	US6331398 Nucleic acid ligands
12/13/2001	WO2001094381A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
12/13/2001	WO2001094332A1 Profiling of protease specificity using combinatorial fluorogenic substrate libraries
12/13/2001	WO2001034171A3 Peptides for treatment of erectile dysfunction
12/13/2001	WO2001028577A3 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain
12/13/2001	WO2001018181A3 Enzyme inhibitors
12/13/2001	CA2408670A1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
12/12/2001	EP1162206A2 Peptide nucleic acids
12/12/2001	EP1162199A1 1,3,4-oxadiazole derivatives and process for producing the same
12/12/2001	EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection
12/12/2001	EP1161449A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
12/12/2001	EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001	EP0934329B1 Glycoconjugates from modified camptothecin derivates (20-o-linkage)
12/12/2001	EP0750610B1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis
12/11/2001	US6329506 Template-assisted triple helical collagen-like structures
12/11/2001	US6329502 Viricides against human immunodeficiency virus; treatment of aids (acquired immune deficiency syndrome)
12/11/2001	US6329417 Hepatitis C inhibitor tri-pepitides
12/11/2001	US6329379 Oligopeptides for inhibiting hepatitis
12/11/2001	US6329365 Inhibitors of interleukin-1β converting enzyme
12/11/2001	US6329362 Modulation cell adhesion the compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
12/11/2001	US6329336 Glue and crosslinking agent using albumin
12/06/2001	WO2001092292A2 Ghrelin analogs
12/06/2001	WO2001091752A1 Melanocortin receptor agonists
12/06/2001	WO2001091700A2 Composition and method for enhancing elasticity of tissue
12/06/2001	WO2001025257A3 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
12/06/2001	CA2415225A1 Composition and method for enhancing elasticity of tissue
12/06/2001	CA2411667A1 Ghrelin analogs
12/06/2001	CA2410597A1 Melanocortin receptor agonists
12/05/2001	EP1160236A2 Production of mixed acid anhydride and amine compound
12/05/2001	EP1159296A1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly)
12/05/2001	EP1159294A1 Carbohydrate epitope mimic peptides and uses thereof
12/05/2001	EP1159292A2 Compounds having growth hormone releasing activity
12/05/2001	EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
12/05/2001	EP1158996A1 Novel amide derivatives as growth hormone secretagogues
12/05/2001	EP0939765B1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage)
12/05/2001	EP0911327B1 Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient
12/05/2001	EP0845003B1 Novel opioid peptides
12/05/2001	EP0835263B1 Somatostatin peptides
12/05/2001	EP0669912B1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
12/05/2001	EP0644890B1 Oligonucleotide-polyamide conjugates
12/05/2001	CN1325408A Compounds with growth hormone releasing propenties
12/05/2001	CN1325406A Crystalline forms of EtO2C-ch2-(r) Cgl-Aze-Pab-oh
12/04/2001	US6326492 Heterocyclic protease inhibitors
12/04/2001	US6326393 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
12/04/2001	CA2171882C Inhibitors of .beta.-amyloid protein production
11/2001
11/29/2001	WO2001090745A2 Determination of naaladase inhibitors
11/29/2001	WO2001090194A2 Antibodies against particular forms of propsa and use thereof in immunoassays
11/29/2001	WO2001090138A2 SYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER USING OXAZOLIDINONE DERIVATIVES
11/29/2001	WO2001090095A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089282A2 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
11/29/2001	WO2001027138A3 Modulators of srebp processing
11/29/2001	US20010047078 Methods for identifying inhibitors of methionine aminopeptidases
11/29/2001	US20010047030 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
11/29/2001	US20010046981 N-acyl-heterocycle-carboxyamides that are N-substituted with amidino-substituted rings; competitive inhibitors of thrombin; anticoagulants
11/29/2001	US20010046960 N-(2,2,2-trifluoroethyl)glycine derivatives; can be used to prepare lipophilic proteins adapted for crossing the blood brain barrier
11/29/2001	CA2409868A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	CA2405871A1 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
11/28/2001	EP1157998A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors
11/28/2001	EP1157997A1 Novel dipeptide compound and medicinal use thereof
11/28/2001	EP1157987A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
11/28/2001	EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
11/28/2001	EP1157031A1 Oligomers substituted by phosphonic acid ester, phosphonic acid or carbaborane functions and the corresponding pna monomers
11/28/2001	EP1157029A1 Oligopeptide derivatives for the electrochemical measurement of protease activity
11/28/2001	EP1156817A1 Controlling protein levels in eucaryotic organisms
11/28/2001	EP0853483A4 Novel peptides
11/28/2001	CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses
11/27/2001	US6323315 For therapy of cancer
11/27/2001	US6323313 Genetically engineered binding protein for use in diagnosis, detection and treatment of vascular system thrombosis
11/27/2001	US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity
11/27/2001	US6323181 Antitumor agents
11/27/2001	US6323180 Protease inhibitors; inhibit replication of hepatitis c virus
11/27/2001	US6323176 Cyclic peptide antifungal agents
11/27/2001	CA2199941C Synthetic antibiotics
11/27/2001	CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001087927A2 gYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER USING L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER PRECURSORS
11/22/2001	WO2001087926A2 SYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER BY REDUCTIVE ALKYLATION AND CRYSTALLIZATION/ISOLATION IN AQUEOUS METHANOL
11/22/2001	WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087836A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
11/22/2001	WO2001087835A1 Α crystalline form of perindopril tert-butylamine salt

1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 307